|
|
Volumn 89, Issue 5, 2001, Pages 237-248
|
|
Role of monoamine oxidase inhibition and monoamine depletion in fenfluramine-induced neurotoxicity and serotonin release
a
a
a
a
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
3,4 DIHYDROXYPHENYLACETIC ACID;
5 HYDROXYINDOLEACETIC ACID;
AMINE OXIDASE (FLAVIN CONTAINING);
AMPHETAMINE DERIVATIVE;
BRAIN MONOAMINE;
CLORGYLINE;
DOPAMINE;
FENCLONINE;
FENFLURAMINE;
HOMOVANILLIC ACID;
METIROSINE;
MONOAMINE OXIDASE A INHIBITOR;
MONOAMINE OXIDASE B INHIBITOR;
SELEGILINE;
SEROTONIN;
ANIMAL TISSUE;
ARTICLE;
CONTROLLED STUDY;
CORPUS STRIATUM;
DRUG EFFECT;
ENZYME INHIBITION;
HIPPOCAMPUS;
HYPOTHALAMUS;
MALE;
MONOAMINE METABOLISM;
MONOAMINERGIC SYSTEM;
MORTALITY;
NEUROTOXICITY;
NONHUMAN;
PRIORITY JOURNAL;
RAT;
SEROTONIN RELEASE;
SEROTONINERGIC NERVE CELL;
3,4-DIHYDROXYPHENYLACETIC ACID;
ALPHA-METHYLTYROSINE;
ANIMALS;
CLORGYLINE;
CORPUS STRIATUM;
DOPAMINE;
DRUG INTERACTIONS;
FENCLONINE;
FENFLURAMINE;
HOMOVANILLIC ACID;
HYDROXYINDOLEACETIC ACID;
MALE;
MONOAMINE OXIDASE INHIBITORS;
RATS;
RATS, SPRAGUE-DAWLEY;
SELEGILINE;
SEROTONIN;
SEROTONIN ANTAGONISTS;
SEROTONIN UPTAKE INHIBITORS;
TRYPTOPHAN;
ANIMALIA;
|
|
EID: 0035163183
PISSN: 09019928
EISSN: None
Source Type: Journal
DOI: 10.1111/j.1600-0773.2001.890504.x Document Type: Article |
|
Times cited : (7)
|
|
References (3)
|
